Filing Details
- Accession Number:
- 0001236030-24-000015
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2024-05-10 09:04:18
- Reporting Period:
- 2024-05-08
- Accepted Time:
- 2024-05-10 09:04:18
- SEC Url:
- Form 4 Filing
Issuer
Cik | Name | Symbol | Sector (SIC) | IRS No |
---|---|---|---|---|
725363 | Cel Sci Corp | CVM | Biological Products, (No Disgnostic Substances) (2836) | 840916344 |
Insiders
Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
---|---|---|---|---|---|---|---|
1511858 | Eugene Robert Watson | 245 N. Highland Ave Ne Suite 230-296 Atlanta GA 30307 | Yes | No | No | No |
Reported Non-Derivative Transactions
Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|---|---|---|---|---|---|
Common Stock | Acquisiton | 2024-05-08 | 20,000 | $1.39 | 24,431 | No | 4 | P | Direct |
Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|
No | 4 | P | Direct |
Footnotes
- On May 8, 2024, Mr. Watson purchased 20,000 shares of restricted stock directly from the Company at the closing price on May 8, 2024, the most recent closing price available.